Skip to main content

Animations

MJFF Publications

3261 - 3270 of 6516 Results
Title
Year
  • Year
  • 2024
  • 2025
  • 2025
  • 2024
  • 2024
  • 2025
  • 2024
  • 2024
  • 2025
  • 2025
  • Summary Details
    OPEN
    Title: Effect of the mGlu 2 positive allosteric modulator biphenyl‐indanone A as a monotherapy and as adjunct to a low dose of L‐DOPA in the MPTP‐lesioned marmoset
    Journal Name: European Journal of Neuroscience
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1111/ejn.16454
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Characterizing the expression profile of 3R tau pathology in Pick’s disease
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1126/sciadv.adt6105
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Exploring [11C]CPPC as a CSF1R-targeted PET imaging marker for early Parkinson’s disease severity
    Journal Name: Journal of Clinical Investigation
    Publisher: American Society for Clinical Investigation
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1172/jci186591
    Citation Count: 6
  • Summary Details
    OPEN
    Title: P2RX7, an adaptive immune response gene, is associated with Parkinson's disease risk and age at onset
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1177/1877718x241296015
    Citation Count: 1
  • Summary Details
    OPEN
    Title: New insights from a Malaysian real-world deep brain stimulation cohort
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1177/1877718x241297715
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Use of β-adrenoreceptor drugs and Parkinson’s disease incidence in women from the French E3N cohort study
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1177/1877718x251330993
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Dopamine D1–D5 Receptors in Brain Nuclei: Implications for Health and Disease
    Journal Name: Receptors
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/receptors3020009
    Citation Count: 42
  • Summary Details
    OPEN
    Title: Noradrenergic cardiac denervation is associated with gait velocity in Parkinson disease: a dual ligand PET study
    Journal Name: European Journal of Nuclear Medicine and Molecular Imaging
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00259-024-06822-7
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Neuropsychiatric symptoms cluster and fluctuate over time in behavioral variant frontotemporal dementia
    Journal Name: Psychiatry and Clinical Neurosciences
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/pcn.13810
    Citation Count: 9
  • Summary Details
    OPEN
    Title: An atlas of protein phosphorylation dynamics during interferon signaling
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1073/pnas.2412990122
    Citation Count: 7
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.